| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $65.4M | +44.7% |
| Cost of Revenue | $8.7M | +23.1% |
| Gross Profit | $56.8M | +48.7% |
| R&D Expense | $13.6M | +50.8% |
| SG&A Expense | $33.8M | +66.8% |
| Operating Income | -$39.7M | -32.2% |
| Pre-tax Income | -$40.5M | -37.4% |
| Income Tax | $11K | +0.0% |
| Net Income | -$40.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $194.4M | +463.5% |
| Accounts Receivable | $10.9M | +36.7% |
| Inventory | $6.9M | +18.2% |
| Current Assets | $217.3M | +318.1% |
| Total Assets | $225.4M | +282.6% |
| Current Liabilities | $13.0M | -39.9% |
| Total Liabilities | $34.2M | +44.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.0M | -20.2% |
| Capital Expenditures | $1.3M | +36.3% |
| Investing Cash Flow | -$1.6M | +9.4% |
| Financing Cash Flow | $196.5M | +7073.6% |
| Free Cash Flow | -$36.4M | -20.7% |
| -37.3% |
| EPS (Basic) | -$3.39 | +39.0% |
| EPS (Diluted) | -$3.39 | +39.0% |
| Stockholders' Equity |
| $191.2M |
| +270.3% |